Eddy S. Yang

Also affiliated with Markey Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trial”.

Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trial

Annals of Oncology(2023)10.1016/j.annonc.2023.08.003

N/A

1.4DataRank · unranked

61 citations

L.D. Eli, Hans Wildiers, Sara A. Hurvitz, Ángel Guerrero‐Zotano, Nisha Unni +37 more

Obesity diminishes response to PD-1-based immunotherapies in renal cancer

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-000725

N/A

0DataRank · unranked

90 citations

Rachael M. Orlandella, Justin T. Gibson, William J. Turbitt, Gal Wald, Lewis J. Thomas +25 more

Inhibition of the Wnt/β-catenin pathway enhances antitumor immunity in ovarian cancer

Therapeutic Advances in Medical Oncology(2020)10.1177/1758835920913798

N/A

0DataRank · unranked

50 citations

Selene Meza‐Perez, Angelina I. Londoño, Whitney N. Goldsberry, Ashwini A. Katre, Jonathan Boone +16 more

Loss of HAT1 expression confers BRAFV600E inhibitor resistance to melanoma cells by activating MAPK signaling via IGF1R

Oncogenesis(2020)10.1038/s41389-020-0228-x

N/A

0DataRank · unranked

28 citations

Keshab R. Parajuli, Suresh Chava, Rudradip Pattanayak, Deborah L. Della Manna, Deepmala Shrestha +5 more

PSPH promotes melanoma growth and metastasis by metabolic deregulation-mediated transcriptional activation of NR4A1

Oncogene(2021)10.1038/s41388-021-01683-y

N/A

0DataRank · unranked

44 citations

Parmanand Malvi, Deborah Della Manna, Eddy S. Yang, Suresh Bugide, Xuchen Zhang +3 more

Targeted Liposomal Chemotherapies to Treat Triple-Negative Breast Cancer

Cancers(2021)10.3390/cancers13153749

N/A

0DataRank · unranked

28 citations

Ya Zhang, Hanh Giai Ngo, Jia-Shiung Guan, Kai Chen, Qing Wang +6 more

Anti-CD47 Monoclonal Antibody–Drug Conjugate: A Targeted Therapy to Treat Triple-Negative Breast Cancers

Vaccines(2021)10.3390/vaccines9080882

N/A

0DataRank · unranked

33 citations

Ya Zhang, Jia-Shiung Guan, Hanh Giai Ngo, Angela Totoro, Ajeet Singh +7 more

RNF2 ablation reprograms the tumor-immune microenvironment and stimulates durable NK and CD4+ T-cell-dependent antitumor immunity

Nature Cancer(2021)10.1038/s43018-021-00263-z

N/A

0DataRank · unranked

32 citations

Lin Luo, Chuan Xing, Yu Chen, Peng Xu, Li Mao +12 more

Selective suppression of melanoma lacking IFN-γ pathway by JAK inhibition depends on T cells and host TNF signaling

Nature Communications(2022)10.1038/s41467-022-32754-7

N/A

0DataRank · unranked

27 citations

Fengyuan Huang, Xiangmin Zhang, Oluwagbemiga A. Ojo, Yuebin Li, Hoa Q. Trummell +9 more

An in vivo model of glioblastoma radiation resistance identifies long noncoding RNAs and targetable kinases

JCI Insight(2022)10.1172/jci.insight.148717

N/A

0DataRank · unranked

22 citations

Joshua C. Anderson, Zongliang Yue, Thanh Nguyen, Nicholas Eustace, Catherine P. Langford +15 more

The BET Inhibitor JQ1 Potentiates the Anticlonogenic Effect of Radiation in Pancreatic Cancer Cells

Frontiers in Oncology(2022)10.3389/fonc.2022.925718

N/A

0DataRank · unranked

5 citations

Aubrey L. Miller, Ling Zeng, Robert C.A.M. van Waardenburg, Eddy S. Yang, Karina J. Yoon +1 more

Combination Therapy with Trastuzumab and Niraparib: Quantifying Early Proliferative Alterations in HER2+ Breast Cancer Models

Biomedicines(2023)10.3390/biomedicines11082090

N/A

0DataRank · unranked

3 citations

Patrick N. Song, Yun Lü, Andrew C. Burns, Luke Sligh, Eddy S. Yang +2 more

BET inhibition decreases HMGCS2 and sensitizes resistant pancreatic tumors to gemcitabine

Cancer Letters(2024)10.1016/j.canlet.2024.216919

N/A

0DataRank · unranked

13 citations

Samuel C. Fehling, Rebecca B. Vance, Dongquan Chen, Eric Josh Brown, Md. Iqbal Hossain +9 more

A Novel Translational PET Imaging Approach to Quantifying Distal Tumor Immune Activation After Targeted Radiation Therapy and Checkpoint Blockade

International Journal of Radiation Oncology*Biology*Physics(2024)10.1016/j.ijrobp.2023.12.047

N/A

0DataRank · unranked

10 citations

Jessy S. Deshane, Eddy S. Yang, Benjamin M. Larimer, Yujun Zhang

Inhibition of ribonucleotide reductase subunit M2 enhances the radiosensitivity of metastatic pancreatic neuroendocrine tumor

Cancer Letters(2024)10.1016/j.canlet.2024.216993

N/A

0DataRank · unranked

9 citations

Jeremy A. Johnson, Aman Chauhan, Jong Cheol Jeong, Jennifer T. Castle, Tadahide Izumi +8 more

Glioma-initiating cells at tumor edge gain signals from tumor core cells to promote their malignancy

Nature Communications(2020)10.1038/s41467-020-18189-y

N/A

0DataRank · unranked

169 citations

Marat S. Pavlyukov, Daisuke Yamashita, Sadashib Ghosh, Heejin Cho, Noritaka Kagaya +17 more

Feasibility, Safety and Patient Reported Early Clinical Outcomes of Spatially Fractionated Radiotherapy of Unresectable Bulky Tumors Followed by SBRT Delivery

International Journal of Radiation Oncology*Biology*Physics(2025)10.1016/j.ijrobp.2025.06.1188

N/A

0DataRank · unranked

0 citations

Joshua Misa, James A. Knight, W. St Clair, Eddy S. Yang, D. Pokhrel